Jessica B Casaletto

发表

Spatial regulation of receptor tyrosine kinases in development and cancer

Andrea I. McClatchey, A. McClatchey, Jessica B. Casaletto, 2012, Nature Reviews Cancer.

Inhibition of the anaphase-promoting complex by the Xnf7 ubiquitin ligase

T. Hunt, L. Nutt, S. Kornbluth, 2005, The Journal of cell biology.

MM-131, a bispecific anti-Met/EpCAM mAb, inhibits HGF-dependent and HGF-independent Met signaling through concurrent binding to EpCAM

B. Schoeberl, U. Nielsen, A. Raue, 2019, Proceedings of the National Academy of Sciences.

Abstract 1455: RLY-4008, a novel precision therapy for FGFR2-driven cancers designed to potently and selectively inhibit FGFR2 and FGFR2 resistance mutations

D. Bergstrom, R. Valverde, D. Maglic, 2021, Experimental and Molecular Therapeutics.

RLY-4008, the first highly selective FGFR2 inhibitor with activity across FGFR2 alterations and resistance mutations.

D. Bergstrom, D. Shaw, A. Schram, 2023, Cancer discovery.

retSDR1, a short-chain retinol dehydrogenase/reductase, is retinoic acid-inducible and frequently deleted in human neuroblastoma cell lines.

I. Screpanti, C. Thiele, G. Giannini, 2002, Cancer research.

Ezrin-mediated apical integrity is required for intestinal homeostasis

A. McClatchey, M. Curto, I. Saotome, 2011, Proceedings of the National Academy of Sciences.

Merlin/ERM proteins establish cortical asymmetry and centrosome position.

A. Gladden, A. McClatchey, Andrew B Gladden, 2012, Genes & development.

Abstract 1690: Mechanistic characterization of MM-131, a bispecific antibody that blocks c-Met signaling through concurrent targeting of EpCAM

Adnan O. Abu-Yousif, B. Schoeberl, U. Nielsen, 2015 .